- £189.74m
- £173.81m
- £113.34m
- 68
- 29
- 83
- 66
Annual cashflow statement for Science, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.6 | 6.39 | 10.9 | 11.1 | 7.62 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 3.88 | 2.5 | 2.44 | 1.76 | 7.88 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.04 | 4.32 | -3.76 | -2.83 | -14.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5.38 | 17.7 | 14 | 15.3 | 7.91 |
| Capital Expenditures | -0.555 | -0.143 | -0.544 | -0.092 | -0.08 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -4.1 | 0.009 | -18.5 | 0.058 | -12.7 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.65 | -0.134 | -19.1 | -0.034 | -12.8 |
| Financing Cash Flow Items | -5.87 | 0 | — | -0.531 | -0.25 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -7.94 | -3.53 | 13.1 | -6.46 | -8.49 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.58 | 13.6 | 8.12 | 9.32 | -13.7 |